Skip to main content

Table 2 Medians of variations coefficients (%) of ODR obtained for each VOI and each time-point on all patients (patient and validation cohorts)

From: Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for \(^{177}\)Lu-DOTATATE therapy

Organs

Median (1H/6H) [Min; Max]

Median (24H) [Min; Max]

Median (96H/7D) [Min; Max]

LK

4.0% [0.2; 49.5]

8.2% [1.7; 46.8]

26.1% [1.0; 64.9]

RK

5.0% [1.1; 47.8]

8.0% [1.2; 68.5]

14.3% [0.5; 72.2]

L

15.6% [2.2; 45.7]

9.8% [1.4; 47.9]

19.5% [0.4; 139.9]

S

22.3% [8.4; 49.7]

12.1% [0.3; 58.6]

34.7% [16.4; 140.0]

L2–L4

9.5% [1.1; 35.7]

15.4% [2.8; 43.8]

6.2% [1.2; 43.0]

L1–L5

12.5% [0.7; 31.3]

14.9% [0.5; 36.0]

8.0% [0.5; 40.2]

T9–L5

9.4% [2.4; 33.5]

13.5% [2.8; 34.6]

4.4% [0.4; 15.6]